Merrimack Pharmaceuticals Inc. Reports Third Quarter 2012 Financial Results  
11/14/2012 7:29:26 AM

CAMBRIDGE, Mass., Nov. 14, 2012 (GLOBE NEWSWIRE) -- Merrimack Pharmaceuticals, Inc. (Nasdaq:MACK), a biopharmaceutical company discovering, developing and preparing to commercialize innovative medicines paired with companion diagnostics for the treatment of cancer, today announced its third quarter 2012 financial results.